A
Amphastar Pharmaceuticals D
D
AMPH
23.560
USD
0.51
(2.21%)
Market Closed
Volume
24,522
EPS
0
Div Yield
-
P/E
14
Market Cap
1,002,193,961
Articles
Title: Amphastar Pharmaceuticals
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.






